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Abstract
Background: Promoter methylation of N- myc Downstream- Regulated Gene 4 (NDRG4)	
in	 fecal	 DNA	 is	 an	 established	 early	 detection	marker	 for	 colorectal	 cancer	 (CRC).	
Despite	its	connection	to	CRC,	NDRG4	is	predominantly	studied	in	brain	and	heart,	
with	little	to	no	knowledge	about	its	expression	or	role	in	other	organs.	In	this	study,	
we	aimed	to	determine	the	whole-	body	expression	of	NDRG4,	with	a	focus	on	the	
intestinal tract.
Methods: We	investigated	NDRG4	expression	throughout	the	body	by	immunohisto-
chemistry, Western Blotting and in situ mRNA hybridization using tissues from NDRG4 
wild-	type,	heterozygous	and	knockout	mice	and	humans.	In	addition,	we	explored	cell-	
specific	expression	of	NDRG4	in	murine	whole-	mount	gut	preparations	using	immuno-
fluorescence and confocal microscopy.
Key Results: NDRG4	 is	 specifically	 expressed	 within	 nervous	 system	 structures	
throughout the body. In the intestinal tract of both mouse and man, NDRG4 immuno-
reactivity	was	 restricted	 to	 the	enteric	 nervous	 system	 (ENS),	where	 it	 labeled	 cell	
bodies	of	the	myenteric	and	submucosal	plexuses	and	interconnecting	nerve	fibers.	
More	 precisely,	NDRG4	 expression	was	 limited	 to	 neurons,	 as	NDRG4	 always	 co-	
localized	with	HuC/D	(pan-	neuronal	marker)	but	never	with	GFAP	(an	enteric	glial	cell	
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1  | INTRODUCTION
Previously, we identified N-myc Downstream-Regulated Gene 4 (NDRG4) 
promoter	CpG	island	methylation	as	a	promising	early	detection	marker	
for	 colorectal	 cancer	 (CRC),1 an observation that has been indepen-
dently validated.2,3 NDRG4	is	one	of	the	molecular	markers	of	the	FDA-	
approved,	 multi-	target	 stool	 DNA	 test	 (Cologuard®,	 Exact	 Sciences	
Corporation,	Madison,	USA),	which	detects	significantly	more	cancers	
than	the	leading	fecal	immunochemical	test	(FIT),	and	is	currently	used	
as	a	screening	modality	in	the	USA.3 Surprisingly, given its connection 
to	CRC,	the	expression	pattern	and	function(s)	of	NDRG4	in	the	gut	and	
its	role	in	CRC	carcinogenesis	remain	to	be	elucidated.
NDRG4,	also	known	as	SMAP-8 and BDM1, is one of the four mem-
bers	(NDRG1-4) of the NDRG gene family, a group of genes involved 
in cell proliferation, differentiation, development and stress.4	The	en-
coded proteins of this family, characterized by an α/β hydrolase fold, 
share	52%-	65%	sequence	homology	and	are	highly	conserved	in	evolu-
tion in various species.5,6	The	NDRG4 gene was originally characterized 
in	humans	and	encodes	three	isoforms:	NDRG4H	(41	kDa),	NDRG4B	
(37	kDa)	and	NDRG4Bvar(39	kDa).5	Although	all	three	human	isoforms	
have been identified in mouse and rat brain, the latter reveals an addi-
tional	fourth	isoform	(45	kDa)	encoded	by	the	rat	ortholog	of	human	
NDRG4: ‘SMAP-8/BDM1’, while the mouse orthologs correspond to 
NDRG4B and NDRG4Bvar.7,8	In	contrast	to	the	well-	described	ubiqui-
tous	expression	of	NDRG1,	NDRG2	and	NDRG3,	abundant	expression	
of NDRG4 is predominantly observed in brain and heart, suggesting an 
important role of NDRG4 in these organs.5–10 In fact, in the central ner-
vous	system	(CNS),	NDRG4	is	required	for	normal	morphogenesis	of	the	
mouse and zebrafish brain and to protect against neurological deficits 
by	maintaining	physiological	levels	of	brain-	derived	neurotrophic	fac-
tor	(BDNF).7,10 NDRG4 is essential for proper neurite outgrowth, neural 
functions in vitro	and	myelination	of	axons	in	zebrafish.11,12	Consistent	
with	these	observations,	the	Alzheimer	diseased	brain,	which	is	char-
acterized by neuronal degeneration, shows reduced levels of NDRG4.5 
Furthermore,	proper	morphogenesis	of	the	mouse	and	zebrafish	heart	
is regulated by NDRG4 and NDRG4	deficiency	is	associated	with	weak	
contractility and reduced heart rate in zebrafish.10,13 Similarly, varia-
tions	 in	 locus	 16q21	 near	 NDRG4 have been associated with pro-
longation	of	the	QT	interval,	a	risk	factor	for	sudden	cardiac	death.14 
Nevertheless, the molecular mechanisms by which NDRG4 affects the 
above-	described	phenomena	are	still	unknown.
As	 the	 expression	 and	 functional	 role(s)	 of	 NDRG4	 outside	 the	
heart	and	brain	are	largely	unstudied,	we	examined	the	overall	whole-	
body	expression	of	NDRG4,	while	focusing	on	the	intestinal	tract	as	a	
first	step	in	understanding	the	role(s)	of	NDRG4	in	the	gut.	Therefore,	
we	determined	NDRG4	expression	according	the	two	main	specificity	
criteria as described by Pradidarcheep et al.,15 by means of immuno-
histochemistry, in situ mRNA hybridization and Western blotting using 
human, NDRG4	wild-	type	and	NDRG4	knockout	mouse	tissues.	In	addi-
tion,	we	investigated	cell-	specific	expression	of	NDRG4	in	more	depth	
in	murine	whole-	mount	gut	preparations	using	immunofluorescence.
2  | MATERIALS AND METHODS
2.1 | Human
Formalin-	fixed,	 paraffin-	embedded	 human	 normal	 colon	 tissues	 of	
CRC	patients	 (n=5)	were	 retrospectively	 collected	 from	 the	 archive	
of	the	Department	of	Pathology	of	the	Maastricht	University	Medical	
Center.	Written	informed	consent	was	obtained	from	all	study	partici-
pants and the process adhered to local ethics guidelines.
2.2 | Mice
NDRG4	wild-	type	(NDRG4+/+),	heterozygous	(NDRG4+/−)	and	knock-	out	
(NDRG4−/−)	mice	(C57BL/6	genetic	background)	were	kindly	provided	
marker).	 Furthermore,	 NDRG4	 was	 expressed	 in	 various	 neuropeptide	 Y	 positive	
	neurons,	but	was	only	found	in	a	minority	(~10%)	of	neurons	expressing	neuronal	nitric	
oxide	synthase.
Conclusions and Inferences: NDRG4	 is	 exclusively	 expressed	 by	 central,	 peripheral	
and	enteric	neurons/nerves,	 suggesting	a	neuronal-	specific	 role	of	 this	protein.	Our	
findings	raise	the	question	whether	NDRG4,	via	the	ENS,	an	understudied	component	
of	the	tumor	microenvironment,	supports	CRC	development	and/or	progression.
K E Y W O R D S
biomarker,	colorectal	cancer,	enteric	nervous	system,	myenteric	plexus,	NDRG4
KEY POINTS
•	 Despite	 its	 excellent	 performance	 as	 biomarker,	 the	
	expression	and	function	of	NDRG4	in	the	gut	and	its	role	
in	CRC	carcinogenesis	are	unknown
•	 NDRG4	is	specifically	expressed	in	neurons	of	the	enteric	
nervous system
•	 The	specific	expression	of	NDRG4	unravels	a	novel	neuron-
specific role of this protein and opens the discussion of 
whether	the	ENS	contributes	to	CRC	carcinogenesis
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by	Prof.	Baldwin	(Vanderbilt	University	Medical	Center)16 and charac-
terized	by	genotyping	PCR	(See	“Genotyping”).	Animals	were	age-	and	
gender	matched	 and	housed	 in	 groups	of	3-	5	under	 standard	 condi-
tions	having	 free	 access	 to	 food	and	water.	One-	year	old	NDRG4+/+, 
NDRG4+/− and NDRG4−/− mice were sacrificed, tissues were harvested 
and	either	 snap-	frozen	 for	 protein	 isolation	or	 fixed	 in	4%	 formalde-
hyde for  immunohistochemistry. In addition, 2 month old NDRG4+/+ 
and NDRG4−/− mice were sacrificed, followed by removal of brain and 
intestines	 for	 immunostainings	on	brain	and	whole-	mount	gut	prepa-
rations.17	 Animal	 experiments	 were	 approved	 by	 the	 Committee	 of	
Animal	Welfare	of	Maastricht	University	and	performed	according	 to	
Dutch regulations.
2.3 | Genotyping
To	identify	carriers	of	the	NDRG4	wild-	type	and	deletion	allele,	puri-
fied	DNA	was	examined	by	PCR.	Genomic	DNA	was	purified	with	the	
Gentra	Puregene	Mouse	tail	kit	(Qiagen,	Maryland,	USA)	according	to	
manufacturer’s	 instructions.	For	 the	detection	of	each	allele,	 a	PCR	
was performed with the NDRG4	primer	mix	listed	in	Table	1.	The	PCR	
reaction	mix	contained	100	ng	genomic	DNA,	10	μL	REDExtract-	N-	
Amp	PCR	Reaction	Mix	(REDExtract-	N-	Amp™	Tissue	PCR	Kit,	Sigma-	
Aldrich,	St.	Louis,	MO,	USA)	and	0.8	μL	primer	mix	(10	μM)	in	a	final	
volume of 20 μL.	The	PCR	was	performed	using	 the	Biorad	T100™	
thermal	 cycler	 (Biorad)	with	 the	 following	conditions:	 (i)	 initial	 incu-
bation:	94°C	for	3	minutes,	(ii)	35	cycles:	94°C	for	30	seconds—60°C	
(annealing	temperature)	for	30	seconds—72°C	for	1	minutes,	and	(iii)	
final	elongation:	72°C	for	10	minutes.	PCR	products	were	detected	in	
a	1.5%	(w/v)	agarose	gel	in	0.5×	Tris-	borate-	EDTA	(TBE)	buffer.	The	
NDRG4	wild-	type	 locus	 is	 identified	by	a	203	and	957	bp	fragment,	
whereas a 320 bp band identifies the deletion allele.
2.4 | Protein isolation and western blotting
Brain, heart and colon tissues from NDRG4+/+, NDRG4+/− and NDRG4−/− 
mice	were	homogenized	in	RIPA	buffer	(Pierce	Technology,	Rockford,	
Illinois,	USA)	containing	protease	inhibitors	(1	“complete”	pill/50	mL,	
Roche,	 Mannheim,	 Germany),	 and	 resolved	 in	 SDS-	gel	 electropho-
resis.	 Protein	 transfers	 were	 probed	 overnight	 (4°C)	 with	 mouse	
anti-	human	NDRG4,	 clone	 2G3	 (1:500;	 H00065009-	M01;	 Abnova,	
Taipei	City,	Taiwan),	rabbit	anti-	human	NDRG4	(1:1000;	#9039;	Cell	
Signaling,	 Leiden,	 The	Netherlands)	 and	 β-	actin	 (1:200	 000;	 Sigma-	
Aldrich).	Bound	antibodies	were	visualized	by	an	HRP-	linked	second-
ary	anti-	rabbit	or	anti-	mouse	antibody	(1	hour,	RT,	Cell	Signaling)	and	
chemiluminescence	(ECL,	Pierce	Technology,	Rockford,	Illinois,	USA).
2.5 | Immunohistochemistry
Three	 μm	 thick	 paraffin	 sections	 of	 every	 organ	 of	 NDRG4+/+ and 
NDRG4−/−	mice	and	human	colon	were	deparaffinized	in	xylene	and	re-
hydrated	in	graded	alcohols.	To	quench	endogenous	peroxidase	activity,	
the	slides	were	incubated	with	0.3%	hydrogen	peroxide	in	methanol	
for	20	minutes.	Antigen	 retrieval	was	performed	by	boiling	 the	 sec-
tions	in	Tris-	EDTA	buffer	(pH	8.0;	Klinipath,	Duiven,	The	Netherlands)	
or	Dako	target	retrieval	solution	(pH	6.0;	Dako,	Santa	Clara,	CA,	USA),	
followed	by	blocking	nonspecific	antibody	binding	with	PBS	contain-
ing	20%	 fetal	 bovine	 serum	and	0.1%	Tween.	 Sections	where	 incu-
bated	overnight	at	4°C	with	the	primary	antibodies:	mouse	anti-	human	
NDRG4,		clone	2G3	(1:500,	Abnova)	or	rabbit	anti-	human	NDRG4	anti-
body	(Mouse	brain	and	other	organs	1:500	and	1:250,	resp.;	Human	
colon,	 1:25;	 Cell	 Signaling)	 diluted	 in	 PBS/0.5%BSA/0.1%Tween.	
After	incubation	with	the	biotinylated	anti-	mouse	secondary	antibody	
(1:250;	 RPN1001v1;	Amerscham	Biosciences,	 Piscataway,	NJ,	USA)	
followed	by	the	Avidin-	Biotin	Complex	detection	method	(ABC;	1:500;	
Dako	Cytomation,	Glostrup,	Denmark)	or	incubation	with	horse	radish	
peroxidase-	conjugated	 anti-	rabbit	 IgGs	 (poly-	HRP,	 Immunologic,	
Duiven,	 The	 Netherlands),	 bound	 antibodies	 were	 visualized	 using	
3,3’-	diaminobenzidine	 (DAB,	Dako)	 as	 a	 chromogen	 (brown	 precipi-
tate).	 Slides	were	 counterstained	with	 hematoxylin,	 dehydrated	 and	
mounted. In addition, to diminish recognition of endogenous mouse 
immunoglobins by the mouse primary antibody, slides were subse-
quently	stained	with	the	mouse	anti-	human	NDRG4	antibody,	clone	
2G3	(1:500;	H00065009-	M01;	Abnova)	using	the	Vector®	M.O.M.™	
Immunodetection	Kit	according	to	manufacturer’s	instructions	(Vector	
Labs,	Burlingame,	CA,	USA).	Negative	controls	for	primary	anti	bodies	
were monitored by staining of NDRG4−/− tissues and omission of pri-
mary antibodies from NDRG4+/+	 slides.	 Images	were	 acquired	 at	RT	
using	a	Nikon	DMX1200	digital	camera	and	the	ACT-	1	v2.62	software	
from	Nikon	Corporation	(Amsterdam,	The	Netherlands).
2.6 | Immunofluorescence
Immunostainings	 were	 performed	 on	 brain	 slices	 and	 whole-	mount	
gut preparations as previously described.17 Briefly, ileum and colon 
of NDRG4+/+ and NDRG4−/− mice were collected, opened along the 
mesenteric	border,	stretched	and	pinned	flat	with	insect	pins	(0.2	mm,	
Agar	Scientific,	Stansted,	UK)	in	a	Sylgard-	lined	dissection	dish	(Sylgard	
184	Elastomer,	Down	Corning,	Auburn,	MI,	USA)	with	Krebs	solution	
bubbled with 95% O2-	5%	CO2.	The	mucosal	 and	submucosal	 layers	
were	 removed,	 tissues	 fixed	 for	 30	minutes	 (4°C)	 in	 paraformalde-
hyde	 (4%	 in	PBS)	and	 rinsed	 in	PBS.	To	visualize	 the	myenteric	and	
TABLE  1 PCR	primers	for	genotyping
Target Forward primer Reverse primer Annealing temp. (°C)
NDRG4 mouse
NDRG4	4HLOX1 TAGGCAGGGGCAGGTGGGTTTGT 60
NDRG4	4HLOX2 GGCGTCCTGATGTCATGTTCCTGT 60
NDRG4	4H776  GCTCCCACTCCAATGCCAATC 60
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submucosal	 plexus	 the	 circular	 or	 longitudinal	muscle	 layer,	 respec-
tively, were peeled. Brain and gut tissues were permeabilized in 0.5% 
tritonX-	100	 and	 incubated	 in	 blocking	 solution	 (4%	 goat/donkey	
serum),	 followed	 by	 an	 overnight	 incubation	 (4°C)	with	 the	 primary	
antibodies	 diluted	 in	 blocking	 solution:	 rabbit	 anti-	NDRG4	 (1:500,	
Cell	 Signaling),	 chicken	anti-	GFAP	 (1:5000;	Abcam,	Cambridge,	UK),	
human	anti-	HuC/HuD	(1:500;	Invitrogen	Life	Technologies,	Rockford,	
Illinois,	 USA),	 sheep	 anti-	neuronal	 NO-	synthase	 (1:400;	 Santa	 Cruz	
Biotechnologies,	 Delaware,	 CA,	 USA),	 rabbit	 anti-	calretinin	 (1:2000;	
Chemicon,	 Darmstadt,	 Germany),	 rat	 anti-	neuropeptide	 Y	 (1:500;	
Eugene	Tech	 International	Allendale,	NJ,	USA)	 for	whole-	mount	gut	
preparations;	 rabbit	 anti-	NDRG4	 (1:500;	 Cell	 Signaling)	 and	 mouse	
anti-	human	 NeuN	 (1:100,	 Chemicon)	 for	 brain	 slides.	 After	 rinsing,	
tissues were incubated for 2 hours with the fluorescently labeled 
secondary	 antibodies:	 anti-	human	 Alexa594,	 anti-	mouse	 Alexa594,	
anti-	rabbit	 Alexa488,	 anti-	sheep	 Alexa488,	 anti-	rat	 Alexa488	 (all	
1:1000;	 Molecular	 probes,	 Invitrogen,	 Belgium),	 anti-	rabbit	 AMCA	
or	anti-	chicken	AMCA	(both	1:250;	Jackson	Immuno	Research	Labs,	
West	 Grove,	 PA,	 USA).	 Samples	 were	 mounted	 with	 Vectashield™	
mounting	medium	 (Vector	Labs,	Burlingame,	CA,	USA).	Preparations	
were	imaged	with	a	Zeiss	LSM780	confocal	microscope	(Cell	imaging	
Core,	KU	Leuven).
2.7 | In situ mRNA hybridization
In situ mRNA	 hybridization	 was	 performed	 on	 paraffin-	embedded	
brains and intestinal Swiss rolls of NDRG4+/+ and NDRG4−/− mice using 
digoxigenin	(DIG)	labeled	riboprobes	(DIG	RNA	Labeling	Kit,	SP6/T7,	
Roche)	 for	NDRG4	nucleotide	positions	1269-	1777	 (NDRG4-	A)	and	
1811-	2343	 (NDRG4-	B)	 of	 mouse	 NDRG4	 (NM_145602,	 Table	2).7 
Four	μm sections were dried upright, deparaffinized, rehydrated and 
washed.	Tissues	were	permeabilized	with	0.1%	pepsin	in	0.2N	HCl	for	
5	minutes	(37°C)	and	post-	fixed	in	4%	paraformaldehyde	(4°C).	Fixed	
sections	were	then	treated	twice	with	100	mM	glycine	in	1xPBS	and	
prehybridized	 (37°C)	 for	 45	minutes	 in	 prehybridization	 buffer	 (2×	
SCC,	50%	(v/v)	deionized	formamide,	40%	(v/v)	DEPC-	treated	H2O).	
NDRG4	mRNA	was	 detected	 overnight	 at	 37°C	with	 the	 preheated	
hybridization	buffer	(2×	SCC,	50%	(v/v)	formamide,	10%	dextran	sul-
phate,	 10	mM	DTT,7,5%	DEPC-	H2O,	 1×	Denhardts	 solution,	 1	mg/
mL	yeast	tRNA,	1	mg/mL	denatured	and	sheared	salmon	sperm	DNA)	
containing	 a	 mixture	 of	 both	 antisense	 or	 sense	 probes	 (1	μg/mL).	
After	a	serial	wash	in	descending	concentrations	(2×,	1×	and	0.1×)	of	
SCC	buffer,	tissue	RNA	was	digested	by	RNase	A	(Roche),	followed	by	
a	serial	wash	in	ascending	SCC	concentrations	(1×	and	2×)	and	buffer	
1	(100	mM	Tris-	HCl,	150	mM	NaCl).	Sections	were	then	blocked	for	
two	hours	(0.1%	Triton	X-	100,	2%	normal	sheep	serum	in	buffer	1)	and	
incubated	with	 1:100	 anti-	DIG	 alkaline	 phosphatase	 Fab	 fragments	
(Roche)	for	1	hour	at	37°C.	Following	washes	in	buffer	1	and	2	(100	mM	
Tris-	HCl,	100	mM	NaCl,	50	mM	MgCl2),	 the	chromogenic	substrates	
nitro-	blue	 tetrazolium	 chloride	 and	 5-	bromo-	4chloro-	3indolyl	 phos-
phate	 (Roche),	 dissolved	 in	 buffer	 2	 containing	 5	mM	 levamisole,	
were	 used	 to	 detect	 hybridized	 alkaline	 phosphatase	 activity.	Once	
the  signal reached optimal intensity, the color reaction was stopped 
(10	mM	 Tris-	HCl,	 1	mM	 EDTA),	 sections	 were	 counterstained	 with	 
nuclear	 fast	 red,	 clarified	 in	 tap	 water	 and	 mounted	 in	 imsol	 (1:3).	
Tissue	 sections	 of	NDRG4−/− and NDRG4+/+ mice immersed in anti-
sense or sense riboprobes, respectively, served as negative controls. 
Images	were	acquired	as	described	for	IHC	images.
3  | RESULTS
3.1 | The Cell Signaling antibody is able to 
specifically target NDRG4
We	first	characterized	the	specificity	of	both	anti-	NDRG4	antibodies	
using tissues of NDRG4+/+, NDRG4+/− and NDRG4−/− mice in Western 
Blotting	 and	 immunohistochemistry	 (Figure	1).	 Western	 Blotting	 
revealed	 that	 both	 antibodies	 could	 discriminate	 all	 known	NDRG4	
isoforms	 in	 various	 tissues,	 including	 proximal	 and	 distal	 colon	 of	
NDRG4+/+ and NDRG4+/−	mice	(Figure	1A,B).	However,	successful	dele-
tion of NDRG4 in NDRG4−/− mice was only confirmed after application 
of	the	Cell	Signaling	antibody.	The	specificity	of	the	Abnova	antibody,	
however, could not be confirmed, as the signal was still detectable in 
NDRG4−/−	tissues	and	several	non-	specific	bands	of	about	50-	55	kDa	
were	recognized.	Non-	specific	recognition	of	NDRG4	by	the	Abnova	
antibody was also confirmed by the similar staining pattern observed 
in	all	examined	 tissues	of	NDRG4−/− and NDRG4+/+	mice	 (Figure	1C).	
The	Cell	 Signaling	 antibody	 on	 the	 other	 hand,	 detected	NDRG4	 in	
NDRG4+/+, but not in NDRG4−/−	tissues	(Figure	1D).	Thus,	only	the	Cell	
Signaling	 antibody	 (#9039)	 is	 able	 to	 specifically	 target	NDRG4	 and	
was	therefore	further	used	to	comprehensively	study	the	expression	of	
NDRG4 throughout the body and specifically within the gut.
3.2 | NDRG4 is specifically expressed within the 
enteric nervous system of both mouse and man
Characterization	of	NDRG4	expression	in	the	gastrointestinal	(GI)	tract	
(ie,	 stomach,	 small	 and	 large	 intestine)	 of	NDRG4+/+ and NDRG4−/− 
mice using immunohistochemistry, revealed that NDRG4 is specifically 
expressed	within	the	nervous	system	of	the	gut,	ie,	the	enteric	nerv-
ous	system	(ENS;	Figure	2).18	More	precisely,	NDRG4	is	expressed	in	
the	cytoplasm	of	cell	bodies	 inside	ganglia	of	 the	myenteric	plexus,	
TABLE  2 Probes for in situ mRNA hybridization
Target Forward primer Reverse primer Annealing temp. (°C)
NDRG4 mouse
NDRG4-	A TTATTTAAAAAGAAATGAGGGGATC TTGCCTCAGGGTGGGACAA 58.5	(F)-	60.2	(R)
NDRG4-	B GTTAAAATGTTGATTGCTGTGTATGC ACTCCAGAGCAGTCTAGAAATGGC 60.5	(F)-	60.9	(R)
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located between the outer longitudinal and inner circular muscle layer 
along the entire GI tract and within the ganglia of the submucosal 
plexus	 (Figure	2A).	 The	 nerve	 fiber	 bundles	 	connecting	 the	 ganglia	
in	both	plexuses	also	showed	NDRG4	expression.	Furthermore,	 the	
nerves	innervating	the	outer	and	inner	muscularis	externa,	muscularis	
mucosae and those projecting into the mucosa also showed NDRG4 
immunoreactivity.	As	explained	above,	specificity	of	the	antibody	was	
monitored by NDRG4 immunohistochemistry on the gut of NDRG4−/− 
mice.	Representative	immunohistochemical	 images	(Figure	2A)	show	
that the intestinal tract of NDRG4−/− mice still contains all the ENS 
structures described above, ie, ganglia of the myenteric and submu-
cosal	 plexus	 and	 interconnecting	 nerve	 fibers,	 but	 does	 not	 display	
NDRG4	immunoreactivity,	confirming	the	absence	of	NDRG4	expres-
sion.	Furthermore,	in situ mRNA hybridization confirmed that NDRG4 
is	 specifically	 expressed	within	 the	ENS	of	NDRG4+/+ mice, but not 
in NDRG4−/−	 mice	 (Figure	2A).	 Similar	 to	 that	 described	 in	 mouse,	
human intestinal specimens displayed NDRG4 immunoreactivity in 
the	ganglia	of	both	plexuses,	in	nerve	fibers	connecting	these	ganglia	
and within the fibers innervating both muscle layers of the muscularis 
externa	and	muscularis	mucosae,	 as	 shown	 in	Figure	2B.	Compared	
to mouse, the mucosal projecting nerve fibers showed more robust 
NDRG4	immunoreactivity.	Together	these	data	indicate	that	NDRG4	
is	specifically	expressed	within	the	ENS	of	mice	and	humans.
3.3 | NDRG4 is expressed within enteric neuronal  
cells
Whole-	mount	preparations	of	the	submucosal	and	myenteric		plexuses	
of the NDRG4+/+ and NDRG4−/− small and large intestine were used 
to	 explore	 what	 types	 of	 enteric	 neurons	 express	 NDRG4.	 Since	
similar	 results	 were	 observed	 in	 above-	mentioned	 whole-	mount	
preparations,	only	data	 from	the	colonic	myenteric	plexus	are	shown	
(Figure	3).	 Immunofluorescent	 triple	 labeling	 revealed	 that	within	 the	
gut of NDRG4+/+	 mice,	 NDRG4	 is	 exclusively	 expressed	 within	 the	
 cytoplasm of enteric neurons, as NDRG4 positive cells were always 
labeled	 for	 the	pan-	neuronal	marker	HuC/D,	but	never	co-	expressed	
the	glial	cell	marker	GFAP	(Figure	3A).	Even	though	NDRG4	localized	
in  enteric  neurons throughout all areas of the ENS, not all enteric neu-
rons	(HuC/D	positive)	expressed	NDRG4	(Figure	3A).	To	further	inves-
tigate	 visual	 differences	 in	 the	organization	of	 the	plexuses	between	
NDRG4+/+ and NDRG4−/− mice, the two main neuronal subsets, posi-
tive	 for	 the	neuronal	markers	nitric	oxide	 synthase	 (nNOS;	 inhibitory	
F IGURE  1 The Cell Signaling, but not the Abnova antibody specifically targets NDRG4.	(A,B)	Western	Blotting	analysis	of	NDRG4+/+, NDRG4+/− 
and NDRG4−/−	brain,	heart	and	colon	(P,	proximal;	D,	distal)	using	the	Abnova	(A)	and	Cell	Signaling	antibody	(B). Both antibodies recognize all 
three	well-	known	isoforms:	NDRG4B	(37	kDa),	NDRG4Bvar	(39	kDa)	and	NDRG4H	(41	kDa)	in	NDRG4+/+ and NDRG4+/− tissues. Open triangles 
indicate	non-	specific	bands	(50-	55	kDa)	identified	by	the	Abnova	antibody	(A).	*	indicates	successful	detection	of	NDRG4	ablation	only	after	
application	of	the	Cell	Signaling	antibody	(B).	β-	actin	is	used	as	loading	control.	(C,D)	Brain,	heart	and	colon	sections	from	1-	year	old	NDRG4+/+ 
and NDRG4−/−	mice	were	subjected	to	IHC	with	the	Abnova	(C)	and	Cell	Signaling	antibody	(D).	Positive	signals	(brown)	detected	by	the	Abnova	
antibody are not affected by absence of NDRG4	and	differ	from	the	highly	selective	staining	pattern	produced	by	the	Cell	Signaling	antibody.	
Scale bars, 50 μm	in	C	and	D
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motor	neurons	 and	descending	 interneurons)	 or	 calretinin	 (excitatory	
motor	neurons),	were	studied	in	combination	with	HuC/D	(Figure	3B).	
The	 overall	 neuronal	 population	 in	NDRG4+/+ and NDRG4−/− colon is 
fairly	similar	as	indicated	by	analogous	HuC/D	positivity	and	calretinin	
and	nNOS	staining	(Figure	3B).	Nevertheless,	our	preliminary	observa-
tions reveal that the NDRG4 and nNOS positive population were al-
most	completely	different	from	each	other	(Figure	3C).	More	precisely,	
	neurons	 that	 express	NDRG4	are	 almost	 exclusively	nNOS	negative:	
only	3%	of	the	NDRG4	positive	enteric	neurons	also	expressed	nNOS	
and vice versa, only 10% of the nNOS population was immunoreactive 
for	NDRG4.	Finally,	to	investigate	if	NDRG4	is	expressed	by	secreto-
motor	neurons,	 the	 co-	localization	of	NDRG4	with	 the	 secretomotor	
neuron	marker	NPY	was	studied.	Overlap	of	NDRG4	with	NPY	was	ob-
served	 in	neuronal	cell	bodies	of	 the	 intestinal	plexuses	of	NDRG4+/+ 
mice	(Figure	3D).	In	conclusion,	NDRG4	is	expressed	in	different	sub-
sets of enteric neurons.
3.4 | NDRG4 is expressed by neuronal cells in the 
central and peripheral nervous system
Finally,	we	confirmed	that	NDRG4	is	specifically	expressed	within	the	
central	nervous	system	(Figure	4A).	Neurons	in	the	gray	matter	struc-
tures	 of	 the	 cerebrum	 (eg,	 hippocampus	 and	 thalamus),	 cerebellum	
(eg,	Purkinje	and	molecular	 layer)	and	spinal	cord	of	NDRG4+/+ mice 
showed	 specific,	 predominant	 cytoplasmic	 expression	 of	 NDRG4,	
while the white matter, ependymal cells and meninges were negative 
for NDRG4. In the peripheral nervous system, we observed a similar 
staining	pattern	(Figure	4B).	More	specifically,	the	cytoplasm	of	gan-
glia	situated	in	close	proximity	of	every	organ,	ie,	prevertebral		ganglia,	
and of the ventral and dorsal root ganglia showed strong NDRG4 
reactivity.	 Furthermore,	 the	 tiny	nerve	 fibers	 throughout	 peripheral	
organs	itself	(eg,	in	the	bronchial	branch)	also	showed	strong	NDRG4	
immunoreactivity.	Hence,	NDRG4	is	almost	exclusively	expressed	in	
the central, peripheral and enteric nervous system.
4  | DISCUSSION
Our	 previous	 work	 has	 shown	 that	 the	 biomarker	 potential	 of	
NDRG4 is associated with a putative tumor suppressor role in vitro.1 
In  addition, we and various independent groups, described that 
NDRG4		expression	in	the	intestinal	epithelium	decreases	in	the	tran-
sition	 	towards	CRC.1,19,20	However,	all	 these	studies	used	 the	com-
mercially	 available	monoclonal	mouse	anti-	human	NDRG4	 	antibody	
from	 Abnova	 (clone	 2G3,	 H00065009-	M01),	 which	 has,	 to	 our	
knowledge,	 never	 been	 validated	 to	 specifically	 target	 NDRG4.	 In	
this	 study,	 we	 investigated	 the	 whole-	body	 expression	 of	 NDRG4,	
focusing on the GI tract, using two commercially available antibodies: 
the	monoclonal	mouse	anti-	human	NDRG4	from	Abnova	(clone	2G3,	
H00065009-	M01)1,17,20,21	and	polyclonal	 rabbit	anti-	human	NDRG4	
from	Cell	Signaling	(#9039)22,23 according to the specificity criteria,15 
as	a	critical	first	step	in		understanding	the	role(s)	of	NDRG4.
F IGURE  2 NDRG4 is localized within the 
ENS of mouse and man.	A,	Representative	
immunohistochemical	staining	(IHC)	of	
the	GI	tract	(ie,	stomach,	small	intestine	
(duodenum)	and	colon)	and	colonic	in situ 
mRNA hybridization	(ISH)	of	NDRG4+/+ and 
NDRG4−/− mice.	NDRG4	RNA	and	protein	
is	expressed	in	myenteric	and	submucosal	
ganglia	(black	and	open	arrowhead,	
respectively.),	within	interconnecting	nerve	
fibers	throughout	the	plexus,	muscularis	
externa,	muscularis	mucosae	(gray	
arrowhead)	and	mucosae	(black	arrow).	
Deletion of NDRG4 is confirmed at protein 
and	RNA	level.	B,	NDRG4	expression	in	
human colonic specimens is analogous to 
mouse, with more robustly stained mucosal 
projecting	nerve	fibers	(black	arrows).	Scale	
bars, 50 μm	in	A;	and	100	μm in B
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Western blotting and immunohistochemical analysis using tissues 
of NDRG4+/+ and NDRG4−/−	mice	 revealed	that	both	 the	Abnova	and	
Cell	 Signaling	 antibody	 could	 discriminate	 all	 three	 known	 human	
NDRG4	 isoforms.	 However,	 the	 specificity	 for	 NDRG4	 in	NDRG4−/− 
mice	was	only	confirmed	using	the	Cell	Signaling	antibody.	Given	the	
high	sequence	similarity	 (52%-	65%)	between	NDRG4	and	 its	protein	
family	members,	it	is	likely	that	the	Abnova	antibody	recognizes	one	of	
the	other	NDRG	proteins.	According	to	the	phylogenetic	tree,	NDRG4	
shares the closest relation with NDRG2, but either NDRG1, 2 or 3 might 
be	detected,	as	their	main	isoforms	are	43,	39,	or	41	and	40	or	41,	5	kDa	
in size respectively.1,4–7,10	Hence,	this	finding	casts	doubt	on	previously	
published	statements	that	are	based	on	the	expression	of	NDRG4.
Using	 the	 validated	 Cell	 Signaling	 antibody,	 we	 explored	 the	
	expression	 of	 NDRG4	 throughout	 the	 body.	 We	 confirmed	 that	
NDRG4	is	specifically	expressed	within	neurons	of	the	central	nervous	
system	(ie,	brain	and	spinal	cord)7,9	and	observed	this	neuronal-	specific	
expression	 pattern	 through	 the	whole-	body.	More	 depth	 investiga-
tion	of	the	expression	pattern	of	NDRG4	within	the	gut	revealed	the	
 presence of the NDRG4Bvar	 and	NDRG4H	 isoform	 in	murine	 colon	
and	the	specific	expression	of	NDRG4	within	the	ENS.	The	ENS,	the	
so-	called	brain	of	the	gut,	is	an	interconnected	network	of	enteric	neu-
rons and glial cells, predominantly clustered in ganglia of the submu-
cosal	and	myenteric	plexuses,	along	the	entire	GI	tract.24 Interestingly, 
NDRG4	 has	 already	 been	 identified	 with	 DNA	 microarray	 analysis	
F IGURE  3 NDRG4 is expressed in different subsets of enteric neurons.	(A-	D)	Representative	fluorescently	labeled	whole-	mount	preparations	
of	colonic	myenteric	plexus	of	NDRG4+/+ and NDRG4−/− mice. Scale bars, 5 μm.	A,	NDRG4	always	co-	localized	with	HuC/D	(green	vs	red)	but	
never	with	GFAP	(green	vs	blue).	NDRG4−/−	mice	don’t	express	NDRG4,	but	still	possess	enteric	neurons	(red)	and	glial	cells	(blue).	B,	Plexus	of	
NDRG4+/+ and NDRG4−/−	revealed	similarities	in	HuC/D,	calretinin	and	nNOS	positivity	(red,	blue	and	green,	respectively).	C,	NDRG4	positive	
cells	(purple)	are	almost	never	reactive	to	nNOS	(green)	and	nNOS	positive	cells	almost	never	express	NDRG4.	D,	NDRG4	(purple)	co-	localized	
with	NPY	(green)	in	various	cell	bodies	of	secretomotor	neurons
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and in situ	 hybridization	 as	 one	 of	 the	 significantly	 down-	regulated	
genes	 in	 the	aganglionic	bowel	of	mice	 (Retk−/k−)	and	Hirschsprung’s	
patients.25,26	Though,	here	we	describe	for	the	first	time	that	NDRG4	
expression	in	the	gut	is	restricted	to	enteric	neurons	as	NDRG4	always	
co-	localized	with	the	pan-	neuronal	marker	HuC/D,	but	never	with	the	
enteric	glial	cell	marker	GFAP.	Together,	our	findings	raise	the	question	
whether there is a role for the ENS in the development and/or pro-
gression	of	CRC.
While	 the	 reciprocal	 cross-	talk	 between	 nerves	 and	 tumor	 cells,	
together	 with	 the	 concept	 of	 neoneurogenesis/axonogenesis27 
is  nowadays a rapidly evolving field, very little research has been 
	conducted	 to	 unravel	 the	 role	 of	 the	 ENS	 in	 CRC	 development/	
progression. Nevertheless, the importance of the ENS is emphasized 
by	 the	 broad	 range	 of	 (life-	threatening)	 enteric	 neuropathies	 like	
Hirschsprung’s	disease	that	arise	when	alterations	 in	 the	ENS	occur.	
Furthermore,	 it	has	been	described	that	 impairments	 in	the	ENS	can	
contribute to the development and severity of intestinal  inflammation28 
and that inflammatory conditions of the gut are often associated with 
changes in the ENS.29,30	A	 growing	 body	 of	 evidence	 demonstrates	
that proper  functioning of the ENS, ensured by the  interplay  between 
enteric neurons and enteric glial cells, is pivotal to maintain the 
 integrity of the intestinal epithelial barrier to regulate gut homeostasis. 
Neurons,	 like	 enteroendocrine	 cells,	 synthesize	various	neurotrophic	
factors	and	messenger	molecules,	which	are	packaged	in	vesicles	and	
released	 in	 exocytotic	 processes.	 The	 process	 of	 exocytosis	 allows	
a cell to communicate with neighboring cells, ie, other neurons, glia, 
muscle, endothelial, immune and epithelial cells.22	It	is	well-	established	
that	 several	 (enteric)	neuro	transmitters,	 eg,	 acetylcholine,	vasoactive	
intestinal peptide and substance P, can target intestinal stem cells.31 
These	data	suggest	a	potential	role	for	the	ENS	in	the	development/
progression	of	CRC.
NDRG4	has	been	implicated	in	the	route	of	vesicular	transport.	The	
interaction	 of	 NDRG4	 with	 Blood	 vessel	 epicardial	 substance	 (Bves)	
has	 been	 shown	 to	 regulate	 docking	 of	 VAMP-	3	 (SNARE-	protein)	
	positive	 vesicles	 to	 the	 cell	 surface	 and	 the	 subsequent	 cargo	 deliv-
ery	 (eg,	 	fibronectin).32 Similarly, NDRG4 controls vesicle membrane 
	fusion	during	exocytosis	as	NDRG4	knockdown	has	been	associated	
with	a	sharp	reduction	in	the	level	of	another	vesicle-	SNARE	protein,	
SNAP25.12	 The	 SNARE	 proteins,	 including	 SNAP25,	 are	 complexes	
that	are	essential	in	promoting	subcellular	trafficking,	vesicular	fusion	
and	 subsequent	 exocytotic	 release	 of	 neurotransmitters.33	 Hence,	
it	 is	 reasonable	 that	 NDRG4,	 like	 NDRG1	 and	 NDRG2,	 is	 able	 to	
modulate	 subcellular	 vesicle	 trafficking	 and	 exocytotic	 release	 of	
neuro mediators,34,35 thereby regulating neurotransmission and the 
subsequent	targeting	of	the	epithelial	layer.
In summary, we previously observed that the recognition of 
NDRG4	promoter	methylation	in	fecal	DNA	is	a	valuable	tool	for	the	
non-	invasive	detection	of	CRC	and	we	identified	NDRG4	as	a	tumor	
suppressor	gene	 in	CRC	whose	epithelial	expression	decreases	from	
normal	mucosa	 to	CRC.	However,	using	 the	validated	Cell	 Signaling	
antibody,	we	found	that	NDRG4	is	specifically	expressed	within	cen-
tral,	peripheral	and	enteric	neurons	but	not	in	epithelial	cells.	Although	
it	still	remains	to	be	elucidated	how	the	expression	pattern	of	NDRG4	
is	 linked	 with	 its	 biomarker	 performance	 for	 CRC,	 validating	 our	
F I G U R E  4 NDRG4 is	specifically	expressed	in	the	central	en	peripheral	nervous	system.	(A)	Immunohistochemical	and	immunofluorescent	
analysis	of	several	areas	of	the	one-year	old	mouse	brain.	Gray	matter	structures	in	the	cerebrum	and	cerebellum	of	NDRG4+/+ mice are positive 
for NDRG4 (green)	and	various	regions	show	co-localization	of	NDRG4	with	the	neuronal	marker	NeuN	(red):	e.g.	NeuN	positive	cells	in	the	
hippocampal	cortex	(pyramidal	neurons	and	granule	cells)	and	in	the	thalamus	co-express	NDRG4.	Cerebral	Purkinje	cells,	which	are	negative	for	
NeuN,	are	strongly	positive	for	NDRG4.	The	gray	matter	of	the	spinal	cord	also	showed	NDRG4	immunoreactivity	within	neuronal	cell	bodies	
(brown).	NDRG4	is	absent	in	all	central	nervous	system	structures	in	NDRG4−/−	mice.	(B)	Representative	images	of	peripheral	tissues	displayed	
NDRG4	expression	in	neurons,	in	prevertebral	and	dorsal	root	ganglia,	and	in	nerves	to,	from	and	within	every	organ	of	the	body	(e.g.	nerve	
fibers	bronchial	branch).	White	scale	bars,	20µm;	and	black	scale	bars,	50µm	in	A	and	B.
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hypothesis	that	NDRG4	can	influence	CRC	development	and/or	pro-
gression via the ENS will have a major impact on current concepts in 
CRC	research.
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